Skip to content

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Using the Electronic Health Record to Identify and Promote Goals-of-Care Communication for Older Patients With Serious Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04281784
Acronym
PICSI-H
Enrollment
2512
Registered
2020-02-24
Start date
2020-04-23
Completion date
2022-09-26
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease, Dementia, Diabetes With End Organ Injury, Heart Failure,Congestive, Kidney Failure, Chronic, Liver Cirrhosis, Lung Diseases, Interstitial, Lung Neoplasm, Neoplasm Metastasis, Peripheral Vascular Disease, Pulmonary Disease, Chronic Obstructive

Keywords

Health care quality, access, and evaluation, Patient care, Inpatients, Health communication, Patient care planning, Palliative care

Brief summary

The objective of this protocol is to test the effectiveness of a Jumpstart intervention on patient-centered outcomes for patients with chronic illness by ensuring that they receive care that is concordant with their goals over time, and across settings and providers. This study will examine the effect of the EHR-based intervention to improve quality of palliative care for patients 55 years or older with chronic, life-limiting illness with a particular emphasis on Alzheimer's disease and related dementias (ADRD). The specific aims are: 1. To evaluate the effectiveness of a novel EHR-based (electronic health record) clinician Jumpstart guide, compared with usual care, for improving the quality of care; the primary outcome is documentation of a goals-of-care discussion in the period between randomization and 30 days following randomization. Secondary outcomes focus on intensity of care: ICU use, ICU and hospital length of stay, costs of care during the hospitalization, and 7 and 30-day hospital readmissions. 2. To conduct a mixed-methods evaluation of the implementation of the intervention, guided by the RE-AIM framework for implementation science, incorporating quantitative evaluation of the intervention's reach and adoption, as well as qualitative analyses of interviews with participants, to explore barriers and facilitators to future implementation and dissemination.

Detailed description

OVERVIEW: This is a large pragmatic trial of the Jumpstart intervention designed to promote goals-of-care discussions for older, seriously ill, hospitalized patients. The trial recruits consecutively eligible patients from three UW Medicine hospitals. The Jumpstart Guide is a communication-priming intervention that addresses hospitalized patients' goals of care. It includes information, drawn from the electronic health record (EHR), identifying the dates and locations of prior advance care planning documents (e.g. living wills, healthcare directives, durable power of attorney for healthcare, and Physician Orders for Life Sustaining Treatments (POLST)) and patients' code status. This information is provided by email to patients' clinicians. The Jumpstart Guide includes tips to improve this communication. The trial will assess the effectiveness of the EHR-based clinician Jumpstart as compared with usual care. This current study is Trial 1 of the R01 Award funding this trial. Trial 2 was initiated following the completion of recruitment for Trial 1. SPECIFIC AIM 1 (for Trial 1): Evaluate the efficacy of the EHR-based clinician Jumpstart compared to usual care for improving quality of care. TRIAL 1 has three components. Component 1- Subject Identification/Recruitment/Randomization: The investigators will use automated methods with EHR data, including natural language processing/machine learning (NLP/ML) approaches, to identify hospitalized patients with serious illness during the first 2-3 days of this specific admission. Screening reports will be produced daily and include all likely eligible patients. Study staff will use these daily screening reports to review individual records of eligible patients for inclusion and exclusion criteria (i.e. verify eligibility). Patients will not be approached for consent. Eligible patients will be assigned to intervention or comparator in a 1:1 ratio. Patients are randomized using variable size blocks and stratified for hospital and ADRD vs. no ADRD. Component 2- EHR-based Clinician Jumpstart Guide: The Jumpstart guide is developed by applying NLP/ML algorithms to both inpatient and outpatient EHR notes (e.g., progress notes, specialty consult notes, alerts and care plans) preceding the current hospitalization. It summarizes the presence/absence of POLST, advance directives and DPOA (durable power of attorney) documentation and the patients' code status. It also provides general recommendations to initiating goals of care discussions. Jumpstart guides are prepared for the intervention group only. Component 3- Delivery of the intervention: For the intervention group, the investigators deliver the Jumpstart guide to the primary hospital team (attending and resident physicians and advanced practice providers) via secure email. The Jumpstart guides are delivered within 1 business day of patient randomization. Study staff monitor the care team of the patient, and if there are any changes, ensure that any new providers receive the Jumpstart guide as well. Comparator: The hospital teams for patients in the control group do not receive Jumpstart guides. Outcome Assessment. Outcomes are obtained from the EHR and use, in part, NLP/ML methods. The primary outcome is EHR documentation of goals-of-care discussions in the 30 days following randomization. Secondary outcomes are measures of intensity of care, including utilization metrics (i.e., ICU admissions, ICU and hospital lengths of stay, 30-day hospital readmissions), costs of care during hospital admission, and estimated costs of implementing the intervention. SPECIFIC AIM 2 (Trial 1): Evaluate implementation of the Jumpstart Guide and identify barriers and facilitators to future implementation. Qualitative evaluation: Clinician recruitment: Study staff will recruit clinicians who were involved with the study to participate in a short interview after the clinician's study involvement with the enrolled patient has ended. Clinician participants will be selected using purposive sampling to ensure a diverse group (e.g., age, race/ethnicity, gender, specialty, year of training). Interview: Using an interview guide developed specifically for this project, interviewers will assess respondents' experience with the intervention and gather suggestions for ways to improve the intervention's content, delivery and implementation, including implementation outcomes (e.g., acceptability, fidelity, penetration, maintenance) that will guide future dissemination of the intervention. Assessment: Interviews are audio recorded, transcribed, and analyzed using thematic analytic methods. Quantitative evaluation: Quantitative evaluation for Specific Aim 2 will be guided by the RE-AIM framework. We will evaluate the intervention's: 1) Reach (% of all identified eligible clinicians, patients and families that participated in the study); 2) Adoption (% of eligible services that participated); and 3) Implementation (the proportion of HTML Jumpstart Guides that were opened by a clinician, proportion of patients for whom an HTML JS guide was sent and for whom a JS was opened by a clinician).

Interventions

The Jumpstart Guide is a communication-priming intervention for clinicians that addresses hospitalized patients' goals of care. The intervention's goal is to prompt clinicians to provide standard of care which includes a discussion with patients or their legal surrogate decision-maker about their goals of care. The one-page Jumpstart Guide provides information to the clinician about prior advance care planning documentation and code status derived from the EHR. The Jumpstart Guides includes tips to improve goals-of-care communication.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility criteria apply to two subject groups: 1) seriously ill adult patients; 2) hospital clinicians. Inclusion Criteria: * PATIENTS. Eligible patients will be those who are: 1) older than 80 years of age; or 2) 55 years of age or older who meet criteria for serious illness. Serious illness encompasses acute illness (e.g. COVID-19) and chronic illnesses (e.g. those included in the Dartmouth Atlas to study end-of-life care: malignant cancer/leukemia, chronic pulmonary disease, coronary artery disease, heart failure, chronic liver disease, chronic renal disease, dementia, diabetes with end-organ damage, and peripheral vascular disease). * CLINICIANS (Interview). Eligible clinicians will be those who are 18 years of age or older, English-speaking, employed at a participating hospital, and have been the clinician of record for an enrolled patient in the trial.

Exclusion criteria

* Reasons for exclusion for any patient include: restricted status (prisoners or victims of violence); legal or risk management concerns (as determined by the attending physician or via hospital record designation).

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Patients With EHR Documentation of Goals of Care DiscussionsAssessed for the period between randomization and 30 days following randomizationThe primary outcome is the proportion of patients who have a goals-of-care (GOC) discussion that has been documented in the EHR in the period between randomization and 30 days following randomization The proportion is the number of patients with GOC documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our NLP/ML methods.

Secondary

MeasureTime frameDescription
Intensity of Care: ICU Admissions 30 DaysAssessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients who received ICU care.
Intensity of Care/ICU Use: ICU AdmissionsAssessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Number of ICU admissions during the patient's (index) hospital stay will be collected from the EHR.
Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)Assessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the ICU within 30 days from randomization will be collected from the EHR.
Intensity of Care: Hospital Readmissions 30 DaysAssessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients readmitted to the hospital following index hospitalization.
Total Hospitalization Costs, Randomization to 30 Days After RandomizationAssessed for the period between randomization and 30 days laterSecondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation.
All-cause Mortality at 30 Days After Randomization (Safety Outcome)30 days after randomizationFrom Washington State death certificates
Total Hospitalization Costs, Randomization to Index Hospitalization DischargeIndex hospital staySecondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation. Assessed for the period between randomization and discharge for the index hospital stay.
Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)Assessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the hospital within 30 days from randomization will be collected from the EHR.

Countries

United States

Participant flow

Recruitment details

PATIENTS recruited from 4/23/20 to 3/26/21. A waiver of informed consent and HIPAA authorization obtained for screening and enrollment.

Pre-assignment details

4567 potentially eligible patients identified; 4395 patients screened (1883 ineligible, 2512 eligible); 2512 enrolled.

Participants by arm

ArmCount
EHR-based Clinician Jumpstart
The EHR-based Jumpstart Guide will be developed by extracting data from the EHR to identify documents uploaded prior to the current hospitalization. It will summarize the presence/absence of POLST, advance directives and DPOA documentation and patients' code status. EHR-based Clinician Jumpstart: The Jumpstart Guide is a communication-priming intervention for clinicians that addresses hospitalized patients' goals of care. The intervention's goal is to prompt clinicians to provide standard of care which includes a discussion with patients or their legal surrogate decision-maker about their goals of care. The one-page Jumpstart Guide provides information to the clinician about prior advance care planning documentation and code status derived from the EHR. The Jumpstart Guides includes tips to improve goals-of-care communication.
1,255
Usual Care
The clinicians (hospital teams) for patients in the control group will not receive Jumpstart guides. These subjects will receive usual care.
1,257
Total2,512

Baseline characteristics

CharacteristicEHR-based Clinician JumpstartUsual CareTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
878 Participants845 Participants1723 Participants
Age, Categorical
Between 18 and 65 years
377 Participants412 Participants789 Participants
Age, Continuous71.8 years
STANDARD_DEVIATION 10.7
71.6 years
STANDARD_DEVIATION 10.9
71.7 years
STANDARD_DEVIATION 10.8
Ethnicity (NIH/OMB)
Hispanic or Latino
77 Participants73 Participants150 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1171 Participants1176 Participants2347 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
7 Participants8 Participants15 Participants
Race (NIH/OMB)
American Indian or Alaska Native
21 Participants24 Participants45 Participants
Race (NIH/OMB)
Asian
143 Participants149 Participants292 Participants
Race (NIH/OMB)
Black or African American
168 Participants148 Participants316 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
4 Participants9 Participants13 Participants
Race (NIH/OMB)
Unknown or Not Reported
37 Participants41 Participants78 Participants
Race (NIH/OMB)
White
882 Participants886 Participants1768 Participants
Region of Enrollment
United States
1255 participants1257 participants2512 participants
Sex: Female, Male
Female
543 Participants513 Participants1056 Participants
Sex: Female, Male
Male
712 Participants744 Participants1456 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
70 / 1,25564 / 1,257
other
Total, other adverse events
0 / 1,2550 / 1,257
serious
Total, serious adverse events
0 / 1,2550 / 1,257

Outcome results

Primary

Proportion of Patients With EHR Documentation of Goals of Care Discussions

The primary outcome is the proportion of patients who have a goals-of-care (GOC) discussion that has been documented in the EHR in the period between randomization and 30 days following randomization The proportion is the number of patients with GOC documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our NLP/ML methods.

Time frame: Assessed for the period between randomization and 30 days following randomization

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
EHR-based Clinician JumpstartProportion of Patients With EHR Documentation of Goals of Care DiscussionsGOC documented433 Participants
EHR-based Clinician JumpstartProportion of Patients With EHR Documentation of Goals of Care DiscussionsGOC not documented822 Participants
Usual CareProportion of Patients With EHR Documentation of Goals of Care DiscussionsGOC documented382 Participants
Usual CareProportion of Patients With EHR Documentation of Goals of Care DiscussionsGOC not documented875 Participants
Comparison: Usual care = reference group; intervention arm = comparison groupp-value: 0.02795% CI: [0.0047, 0.0777]Regression, Linear
Secondary

All-cause Mortality at 30 Days After Randomization (Safety Outcome)

From Washington State death certificates

Time frame: 30 days after randomization

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
EHR-based Clinician JumpstartAll-cause Mortality at 30 Days After Randomization (Safety Outcome)Deceased at 30 days64 Participants
EHR-based Clinician JumpstartAll-cause Mortality at 30 Days After Randomization (Safety Outcome)Alive at 30 days1193 Participants
Usual CareAll-cause Mortality at 30 Days After Randomization (Safety Outcome)Alive at 30 days1185 Participants
Usual CareAll-cause Mortality at 30 Days After Randomization (Safety Outcome)Deceased at 30 days70 Participants
Comparison: Usual care=reference group; intervention arm = comparison groupp-value: 0.58895% CI: [-1.275, 2.249]Regression, Linear
Secondary

Intensity of Care: Hospital Readmissions 30 Days

Secondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients readmitted to the hospital following index hospitalization.

Time frame: Assessed for the period between randomization and 30 days following randomization

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EHR-based Clinician JumpstartIntensity of Care: Hospital Readmissions 30 Days265 Participants
Usual CareIntensity of Care: Hospital Readmissions 30 Days251 Participants
Comparison: Usual care = reference group; intervention arm = comparison groupp-value: 0.47595% CI: [-0.02, 0.043]Regression, Linear
Secondary

Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)

Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the hospital within 30 days from randomization will be collected from the EHR.

Time frame: Assessed for the period between randomization and 30 days following randomization

ArmMeasureValue (MEAN)Dispersion
EHR-based Clinician JumpstartIntensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)21.99 daysStandard Deviation 8.78
Usual CareIntensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)21.63 daysStandard Deviation 9.15
Comparison: Superior outcome for Group 2p-value: 0.31295% CI: [-1.06, 0.338]Regression, Linear
Secondary

Intensity of Care: ICU Admissions 30 Days

Secondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients who received ICU care.

Time frame: Assessed for the period between randomization and 30 days following randomization

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EHR-based Clinician JumpstartIntensity of Care: ICU Admissions 30 Days336 Participants
Usual CareIntensity of Care: ICU Admissions 30 Days348 Participants
Comparison: Usual care = reference group; intervention arm = comparison groupp-value: 0.6195% CI: [-0.043, 0.025]Regression, Linear
Secondary

Intensity of Care/ICU Use: ICU Admissions

Secondary outcomes include measures of intensity of care, including utilization metrics: Number of ICU admissions during the patient's (index) hospital stay will be collected from the EHR.

Time frame: Assessed for the period between randomization and 30 days following randomization

Secondary

Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)

Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the ICU within 30 days from randomization will be collected from the EHR.

Time frame: Assessed for the period between randomization and 30 days following randomization

ArmMeasureValue (MEAN)Dispersion
EHR-based Clinician JumpstartIntensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)27.90 daysStandard Deviation 6.12
Usual CareIntensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)27.83 daysStandard Deviation 6.19
Comparison: Superior outcome for Group 2p-value: 0.7595% CI: [-0.56, 0.404]Regression, Linear
Secondary

Total Hospitalization Costs, Randomization to 30 Days After Randomization

Secondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation.

Time frame: Assessed for the period between randomization and 30 days later

Population: (Data unavailable from Finance Office for two patients.)

ArmMeasureValue (MEAN)
EHR-based Clinician JumpstartTotal Hospitalization Costs, Randomization to 30 Days After Randomization21,908.67 US dollars
Usual CareTotal Hospitalization Costs, Randomization to 30 Days After Randomization22,386.40 US dollars
Comparison: Superior outcome for Group 2p-value: 0.7195% CI: [-0.092, 0.135]other type of regression
Secondary

Total Hospitalization Costs, Randomization to Index Hospitalization Discharge

Secondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation. Assessed for the period between randomization and discharge for the index hospital stay.

Time frame: Index hospital stay

Population: (Data unavailable from Finance Office for two patients.)

ArmMeasureValue (MEAN)
EHR-based Clinician JumpstartTotal Hospitalization Costs, Randomization to Index Hospitalization Discharge24,384.68 US dollars
Usual CareTotal Hospitalization Costs, Randomization to Index Hospitalization Discharge23,724.06 US dollars
Comparison: Superior outcome for Group 2p-value: 0.68595% CI: [-0.162, 0.107]other type of regression

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026